Our current findings indicate that Merlin deficiency enables ROS accumulation—a contrast to the previous study that can be explained by several factors—our studies are centered on breast cancer cells that do not harbor mutations in NF2 and are not conducted in nutrient‐limiting conditions. The gene discussed is NF2; the disease is breast cancer.